The Multiple Chemicals and Actions Model of carcinogenesis. A possible new approach to developing prevention strategies for environmental carcinogenesis
Free accessResearch articleFirst published online November, 2005
The Multiple Chemicals and Actions Model of carcinogenesis. A possible new approach to developing prevention strategies for environmental carcinogenesis
The number of definite and probable human chemical carcinogens identified by IARC approaches between 1987 and June 2004 is reported to be 50 agents. However, overall, given the rapid expansion in the number of chemicals in use, the throughput of the current approach to identifying potential environmental carcinogens is low. The long-term rodent bioassay, a key part of the current approach, identifies many chemicals which eventually turn out to be irrelevant for human health with regard to cancer. A new approach is suggested which focuses on identifying the potency of environmental mixtures for induction of toxicological changes relevant to carcinogenesis (e.g., cell proliferation, chronic inflammation, inhibition of apoptosis, mutagenicity). Details regarding a suggested strategy for prioritization of mixtures are provided with more detailed information regarding mutagenicity as an end point. The long-term rodent bioassay is not included in the proposal (although it is acknowledged that it will continue to be important in premarketing regulatory schemes) for hazard identification. The Multiple Chemicals and Actions Model (MCAM) is developed. In this model the chemical mixtures in the environment act via a number of mechanisms as ‘effectors’ or ‘inhibitors’ of a multistage carcinogenic process. Identifying effectors and inhibitors of the rate-limiting step would be important for preventive strategies. Genetic polymorphisms act as modulators of effector and inhibitor mixtures. It is suggested that the MCAM model could be used in public education programmes to help inform on public health issues regarding cancer and to help avoid future scares which tend to focus on single chemicals. It is acknowledged that there would need to be basic research undertaken to generate appropriate data to support the application of the proposal before it could be used in cancer prevention strategies.
1 Doll R , Peto R.The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today . J National Cancer Inst1981; 66: 1191-1308 .
2.
2 International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall evaluations of carcinogenicity: an updating of IARC monographs Volumes 1-42. Lyon, France: WHO , 1987.
3.
3 Doll R.Commentary. Nature and nurture: possibilities for cancer control . Carcinogenesis1996; 17: 177-184 .
4.
4 International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 69. Polychlorinated dibenzo-paradioxins and polychlorinated dibenzofurans. Lyon, France: WHO , 1997: 33-33.
5.
5 Cole P , Trichopoulos D , Pastides H , Starr T , Mandel JS . Dioxin and cancer: a critical review . Regul Toxicol Pharmacol2003; 38: 378-388 .
6.
6 Commission of the European Communities . Proposal for a regulation of the European Parliament and of the Council concerning the registration, evaluation, authorisation, and restriction of chemicals. Brussels 29.10.2003. COM (2003). 644 final, 2003. Retrieved 17 September, 2004, from: http://europe.eu.int/eur-lex/en/com/pdf/2003/act0644en03/1.pdf
7.
7 Czene K , Lichtenstein P , Hemminki K.Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database . Int J Cancer2002; 99: 260-266 .
8.
8 COM . Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment. Guidance on a strategy for testing of chemicals for mutagenicity. London, England: Department of Health . 23094 1P 0.k January 01 (CWP), 2000. Retrieved 12 October, 2005, from: http://www.advisorybodies.doh.gov.uk/com/guidance.pdf
9.
9 Gold LS , Slone TH , Ames BN . Overview and update analysis of the carcinogenic potency database. In Gold LS , Zeiger E eds. Handbook of carcinogenic potency and genotoxicity databases, chapter 4. New York, USA: CRC Press , 1997: 661-686.
10.
10 Ames BN , Gold LS . The causes and prevention of cancer: the role of the environment . Biotherapy1998; 11: 205-220 .
11.
11 Cohen SM , Meek ME , Klaunig JE , Patton DE , Fenner Crisp PA . The human relevance of information on carcinogenic modes of action: overview . Crit Rev Toxicol2003; 33: 581-589 .
12.
12 Cohen SM , Klaunig J , Meek E , Hill RN , Pastoor T , Lehman-McKeeman L et al. Evaluating the human relevance of chemically induced animal tumours . Toxicol Sci2004; 78: 181-186 .
13.
13 Dybing E.Development and implementation of the IPCS conceptual framework for evaluating mode of action of chemical carcinogens . Toxicology2002; 181-2: 121-125 .
14.
14 Elcock M , Morgan RW . Update on artificial sweeteners and bladder cancer . Regul Toxicol Pharmacol1993; 17: 35-43 .
15.
15 International Agency for Research on Cancer . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 53. Polychlorinated dibenzo-paradioxins and polychlorinated dibenzofurans. Lyon, France: WHO , 1991: 171-171.
16.
16 Ahlborg UG , Lipworrt L , Titus-Ernstoff L , Hsieh CC , Hannberg A , Baron J et al. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence . Crit Rev Toxicol1995; 25: 463-531 .
17.
17 Lopez-Cervantes M , Torres-Sanchez L , Tobias A , Lopez-Carrillo L.Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiological evidence . Environ Health Perspect2004; 112: 207-214 .
18.
18 Pritchard JB , French JE , Davis BJ , Haseman JK . The role of transgenic animal models in carcinogen identification . Environ Health Perspect2003; 111: 444-454 .
19.
19 Renn O.Perception of risks . Toxicol Lett2004; 149: 405-413 .
20.
20 Wold KS , Byers T , Crane LA , Ahnene D.What do cancer survivors believe causes cancer?Cancer Causes Control2005; 16: 115-123 .
21.
21 Vogelstein B , Kinzler KW . Cancer genes and the pathways they control . Nat Med2004; 10: 789-799 .
22.
22 Trosko JE , Rush RJ . Gap junctions as targets for cancer chemoprevention and chemotherapy . Curr Drug Targets2002; 3: 465-482 .
23.
23 Bocchetta M , Carbone M.Epidemiology and molecular pathology at cross roads to establish causation: molecular mechanisms and malignant transformation . Oncogene2004; 23: 6484-6491 .
24.
24 Gunn L , Smith MT . Emerging biomarker technologies. In Buffler P , Rice JR , Baan R , Bird M , Boffetta P eds. Mechanisms of carcinogenesis: contributions of molecular epidemiology. Lyon: IARC Scientific Publications No 157 , 2004.
25.
25 Vogelstein B , Kinzler K.The multistep nature of cancer . Trends Genet1993; 9: 138-141 .
26.
26 Fearon ER , Vogelstein B.A genetic model for colorectal tumorigenesis . Cell1990; 60: 758-767 .
27.
27 Pfeifer GP , Denissenko MF , Tang MS . PCR-based approaches to adduct analysis . Toxicol Lett1998; 102-103: 447-451 .
28.
28 Krewski D , Gaylor DW , Soms AP , Szyszkowicz M.An overview of the report: correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment . Risk Anal1993; 13: 383-398 .
29.
29 Argentin G , Cicchetti R.Genotoxic and anti-apoptotic effect of nicotine on human gingival fibroblasts . Toxicol Sci2004; 79: 75-81 .
30.
30 Lauber N , Ali S , Gooderham N.The cooked food derived carcinogens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity . Carcinogenesis2004; 25: 2509-2517 .
31.
31 Wink DA , Vodovotz Y , Laval J , Laval F , Dewhirst MW , Mitchell JB . The multifaceted roles of nitric oxide in cancer . Carcinogenesis1998; 19: 711-721 .
32.
32 Cassee FR , Groten JP , van Bladeren PJ , Feron VJ . Toxicological evaluation and risk assessment of chemical mixtures . Crit Rev Toxicol1998; 28: 73-101 .
33.
33 Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment . Risk Assessment of Mixtures of Pesticides and Similar substances. September 2002. Retrieved 12 October, 2005, from: http://www.food.gov.uk/science/ouradvisors/toxicity/reports/cocktailreport
34.
34 Suk WA , Olden K.Multidisciplinary research strategies for assessing chemical mixtures to reduce risk of exposure and disease . Int J Occup Med Environ Health2004; 17: 103-110 .
35.
35 Feron VJ , Groten JP . Toxicological evaluation of chemical mixtures . Food Chem Toxicol2002; 40: 825-839 .
36.
36 Martin FL , Carmichael PL , Crofton-Sleigh C , Venitt S , Phillips DH . Genotoxicity of human mammary lipid . Cancer Res1996; 56: 5342-5346 .
37.
37 Martin FL , Cole KJ , Weaver G , Williams A , Millar BC , Grover PL , Phillips DH . Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cell recovered from breast milk . Biochem Biophys Res Commun1999; 257: 319-326 .
38.
38 Klaunig JE , Kamendulis LM . The role of oxidative stress in carcinogenesis . Annu Rev Pharmacol Toxicol2004; 44: 239-267 .
39.
39 Watson RE , Goodman JI . Epigenetics and DNA methylation come of age in toxicology . Toxicol Sci2002; 67: 11-16 .
40.
40 Roebuck BD . Hyperplasia, partial hepatectomy and carcinogenicity of aflatoxin B1 . J Cell Biochem2004; 91: 243-249 .
41.
41 Bogdanffy MS , Valentine R.Differentiating between local cytotoxicity, mitogenesis and genotoxicity in carcinogen risk assessments: the case of vinyl acetate . Toxicol Lett2003; 140-141: 83-98 .
42.
42 Clevers H.At the crossroads of inflammation and cancer . Cell2004; 118: 671-674 .
43.
43 Philip M , Rowley DA , Schreiber H.Inflammation as a tumour promoter in cancer induction . Semin Cancer Biol2004; 14: 433-439 .
44.
44 Jakobisiak M , Lasek W , Golab J.Natural mechanisms protecting against cancer . Immunol Lett2004; 90: 103-122 .
45.
45 Schacter E , Weitzman SA . Chronic inflammation and cancer . Oncology2002; 16: 217-229 .
46.
46 Upham BL , Wagner JG . Toxicant-induced oxidative stress in cancer . Toxicol Sci2001; 64: 1-3 .
47.
47 Heddle JA , Martins HJ , Douglas GR . Treatment and sampling protocols for transgenic mutation assays . Environ Mol Mutag2003; 41: 1-6 .
48.
48 Mally A , Chipman JK . Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat . Toxicology2002; 180: 233-248 .
49.
49 Jiang F , Zhang ZG , Katakowski M , Robin A , Faber M , Zhang F , Chopp M.Angiogenesis induced by photodynamic therapy in normal rat brain . Photochem Photobiol2004; 79: 494-498 .
50.
50 Zeiger E.Mutagens that are not carcinogens: faulty theory or faulty tests?Mutat Res2001; 492: 29-38 .
51.
51 Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment . COC statement on the investigation of interaction between genotype and chemicals in the environment on the induction of cancer COC/02/S4-June 2002. Retrieved 12 October, 2005, from http://www.advisorybodies.doh.gov.uk/coc/geneenv.htm
52.
52 Ibarluzea JM , Fernandez MF , Santa-Marina L , Olea Serrano MF , Rivas AM , Aurrekoetxea JJ et al. Breast cancer risk and combined effect of environmental estrogens . Cancer Causes Control2004; 15: 591-600 .
55 Weisburger JH . Antimutagenesis and anticarcinogenesis, from past to the future . Mutat Res2001; 480-1: 23-25 .
56.
56 Chiao JW , Wu H , Ramaswamy G , Conaway CC , Chung FL , Wang L et al. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenographs by apoptosis and cell cycle arrest . Carcinogenesis2004; 25: 1403-1408 .
57.
57 Kuang YF , Chen YH . Induction of apoptosis in a nonsmall cell human lung cancer by isothiocyanates is associated with P53 and P21 . Food Chem Toxicol2004; 42: 1711-1718 .
58.
58 Wogan GN , Hecht SS , Felton JS , Conney AH , Loeb LA . Environmental and chemical carcinogenesis . Semin Cancer Biol2004; 14: 473-486 .
59.
59 Topinka J , Binkova B , Mrackova G , Stavkova Z , Petereka V , Benes I , Dejmek J , Lenicek J , Pilcik T , Sram RJ . Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population . Environ Mol Mutagen1997; 30: 184-195 .
60.
60 Merlo F , Bolognesi C , Peluso M , Valerio F , Abbondandolo A , Puntoni R.Airborne levels of polycyclic aromatic hydrocarbons, 32P-postlabelling DNA adducts and micronuclei in white blood cells from traffic police workers and urban residents . J Environ Pathol Toxicol Oncol1997; 16: 157-162 .
61.
61 Lopez-Garcia E , Schulze MB , Fung TT , Meigs JB , Rifai N , Manson JE , Hu FB . Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction . Am J Clin Nutr2004; 80: 1029-1035 .
